Company Filing History:
1 out of 1 
1 out of 49 Years Active: 2013-2019
Title: Chi-Hong Chu: Innovator in Influenza Treatment
Introduction
Chi-Hong Chu is a notable inventor based in Taipei, Taiwan. With a focus on pharmaceutical innovations, he holds two patents that address critical health issues, particularly concerning influenza viruses. His work stands out for its potential impact on public health, creating new avenues for treatment and prevention of viral infections.
Latest Patents
Chi-Hong Chu's latest patents include a groundbreaking use of mycophenolate mofetil and its pharmaceutically acceptable salts in the preparation of medicaments to combat influenza viruses. This invention not only targets the standard influenza virus but also specifically addresses drug-resistant strains, thus paving the way for more effective antiviral therapies.
Another significant contribution to his patent portfolio is centered on an extract derived from Schisandrae fructus. This extract, obtained through methods involving water, methanol, or ethanol, showcases inhibitory activities against various influenza virus strains, including H1N1 and its drug-resistant variants. The application of these extracts and purified compounds offers promising pharmaceutical compositions for the treatment or prevention of influenza infections.
Career Highlights
Throughout his career, Chi-Hong has made significant strides in the pharmaceutical industry, with notable tenures at companies like Giant Force Technology Corporation and the National Defense Medical Center. His experience in these institutions has allowed him to refine his expertise in drug development and innovative therapeutic solutions.
Collaborations
Chi-Hong has collaborated with esteemed professionals, including An-Rong Lee and Wen-Liang Chang. Working with these individuals has enabled him to expand the scope of his research and foster an environment of innovation in the pharmaceutical sector.
Conclusion
Chi-Hong Chu's contributions to the field of medicine, particularly in the fight against influenza viruses, underscore the importance of innovation in healthcare. His patents reflect a commitment to developing effective treatments that can significantly benefit patients, especially in the face of evolving viral threats. As he continues to work and collaborate within the industry, his impact is likely to grow, paving the way for future advancements in pharmaceutical research.